
Work Here?
ZS Associates helps organizations optimize their sales and marketing operations through data-driven analytics. The company uses mathematical models and rigorous analysis—originating from Kellogg professors in the 1980s—to size and structure sales teams, design territories, forecast markets, manage data, and design incentive compensation. Its services are delivered as consulting engagements that translate complex analytics into practical business decisions, such as how many salespeople a company needs, how to assign territories, and how to align incentives to drive performance. ZS differentiates itself with a deep, methodical focus on analytics, built from decades of experience and applied across industries beyond its pharmaceutical roots. The company’s goal is to help clients improve performance and return on investment by turning data into actionable sales and marketing solutions.
Industries
Data & Analytics
Consulting
Healthcare
Company Size
10,001+
Company Stage
N/A
Total Funding
N/A
Headquarters
Evanston, Illinois
Founded
1983
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Hybrid Work Options
Flexible Work Hours
Sapio Sciences and ZS partnership highlights formulation technology market momentum. June 16, 2026 By Marianne D'Aquila Acquisition or Partnership Sapio Sciences announced a partnership with management consulting and technology firm ZS to support Sapio Platform deployments across biopharma research and development (R&D) and chemistry, manufacturing, and controls (CMC) laboratories. ZS has also joined the Sapio Partner Program as a consulting partner. The partnership brings together Sapio Platform capabilities with ZS consulting and implementation expertise. Together, the companies will offer services intended to support laboratory digitization, solution architecture, systems integration, change management, validation, and adoption for biopharma organizations. The collaboration is focused on enabling AI-ready, traceable laboratory data and governed workflows with human oversight. These capabilities are important for organizations operating in regulated R&D and CMC environments, where data integrity, scientific context, and compliance requirements are central to laboratory operations. Through the partnership, Sapio Platform customers can access ZS support across the deployment lifecycle, including: * Solution architecture. * System integration. * Change management and adoption. * Validation support. * Data integrity and compliance alignment. * Enterprise data and analytics integration. ZS brings consulting and implementation capabilities across several laboratory and life sciences areas. In R&D and discovery, the partnership is intended to help connect laboratory workflows with enterprise data environments and improve visibility into experiments, samples, and scientific results. In development and CMC, it supports the digitization of development and manufacturing laboratories, including integration with quality, regulatory, and enterprise data systems. The partnership also addresses laboratory informatics and data architecture by supporting scalable environments that connect Sapio Platform with enterprise data pipelines, analytics tools, and AI initiatives. This can help organizations redesign laboratory decision flows and improve cycle time across regulated scientific workflows. This collaboration between Sapio Sciences and ZS directly validates the framework established in ARC's upcoming Formulation Technologies MarketMap and Formulation Management Software MAR. Together, these research tools provide: * A transparent view of a complex supplier landscape. * A disciplined definition of formulation management software market boundaries and core domains. * Actionable insights into adoption patterns, capability trends, and the future of virtual-twin-driven R&D. Whether an organization is modernizing formulation workflows or a supplier is navigating a competitive market, this research offers a clear, forward-looking foundation. For more information about ARC MarketMap, visit: https://www.arcweb.com/arc-marketmap-technology-products-services.
Invest Ontario welcomes ZS Engineering Labs. Investment will create up to 300 high-skilled jobs and strengthen Ontario's AI, digital health, and life sciences ecosystem. TORONTO, Ontario, June 11, 2026 - Invest Ontario welcomes ZS's decision to expand its operations in the province through the creation of a new Engineering Labs in Toronto. The project represents a $165 million investment and is expected to create up to 300 high-skilled jobs over the next three to five years, supporting the company's long term growth in Ontario. ZS, a global management consulting and technology firm, is establishing the Engineering Labs to support its use of advanced technologies, including artificial intelligence, to deliver on its business strategies across healthcare, pharmaceutical and biotech clients. The investment reflects how AI is enabling companies to scale operations, drive innovation and expand high-value work. Invest Ontario worked with the firm to advance the project through strategic advisory services, including benchmarking analysis comparing operating costs across Ontario locations, helping build connections with local governments, universities, and ecosystem partners, and providing guidance on potential provincial and federal support programs to facilitate growth. ZS selected Ontario for its strong pipeline of highly skilled talent, as well as the strength of the province's AI, digital health, and life sciences ecosystem. A Toronto based operation provides access to North American clients and supports continued growth in a globally competitive market. By establishing its Engineering Labs in Toronto, ZS is expanding its AI-enabled capabilities and strengthening its presence in Ontario's innovation ecosystem. The project will contribute to the creation of high-value jobs and reinforce Ontario's position as a destination for advanced, knowledge-based investment. As global competition for technologies intensifies, companies are increasingly seeking stable, reliable and competitive conditions to develop and scale their products, ZS' decision to establish its new Engineering Labs in Toronto is a strong vote of confidence in Ontario's world-class STEM talent and AI ecosystem. We look forward to seeing their lab support the current and future needs of our life sciences and digital health sectors. Hon. Vic Fedeli Minister of Economic Development, Job Creation and Trade The ZS Engineering Labs in Toronto represents a strategic investment in AI talent and capabilities needed to help our clients innovate and transform at scale. Ontario offers a powerful combination of technical expertise, collaborative institutions, and a strong innovative ecosystem, making it an ideal location for advancing digital, Data and AI solutions across our client segments. Mahmood Majeed Principal, Head of Technology, ZS Ontario continues to demonstrate that it can deliver the talent, capability, and predictability companies need to grow. This investment strengthens our position in AI, digital health, and life sciences, and reflects our ability to compete for knowledge-based projects that translate into jobs, investment, and long-term economic growth for Ontario. At Invest Ontario, we work alongside companies as they grow, engage key stakeholders and connect with the ecosystem they need to scale successfully and build long-term operations in Ontario. Khawar Nasim CEO, Invest Ontario About Invest Ontario. Invest Ontario is the dedicated agency for investment attraction in the province. We serve as global businesses' partner and one-window access to Ontario, providing expertise and tailored services throughout their investment journey. With a focus on the advanced manufacturing, life sciences and technology sectors, we are committed to securing strategic investments that create jobs, generate returns to the province and drive Ontario's long-term economic growth and global competitiveness. About ZS. ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000 employees in over 40 offices worldwide. To learn more, visit www.zs.com or follow us on LinkedIn. Media contacts. Stephen Chiang Director, Communications, Invest Ontario INVEST ONTARIO. HERE TO HELP.
ZS, a global management consulting and technology firm, has launched two new AI-powered application suites for the life sciences industry: ZAIDYN Medical and ZAIDYN Content. The platforms are part of ZS's expanded ZAIDYN intelligence platform, which uses agentic AI to address regulated, high-stakes workflows. ZAIDYN Medical helps medical affairs teams identify and engage key opinion leaders whilst generating insights 50-70% faster. The suite is backed by issued US patents and pending applications focused on AI-driven medical intelligence. ZAIDYN Content accelerates the life sciences content supply chain from creation through medical, legal and regulatory approval. Already deployed at enterprise scale, it has processed over 100,000 assets, reducing cycle time for personalised content by more than 67%. The platform embeds compliance and medical intelligence directly into review workflows.
ZS Advances Agentic AI Applications for Life Sciences With Launch of ZAIDYN Medical(TM) and ZAIDYN Content(TM). Building on decades of life sciences expertise, ZS is scaling agentic AI from strategy to governed execution across medical and commercial workflows. EVANSTON, Ill.-(BUSINESS WIRE)-ZS, a global management consulting and technology firm, today announced its expansion of ZAIDYN(R), a life sciences intelligence platform powered by agentic AI. The expansion introduces ZAIDYN Medical(TM) and ZAIDYN Content(TM)- two new purpose-built, modular application suites that combine deep domain expertise with data, advanced analytics and AI to address specific business challenges. Together, these launches reflect ZS's leadership in applying agentic AI to regulated, high-stakes workflows, helping life sciences organizations accelerate decisions and support execution with the governance, scientific rigor and compliance the industry demands. ZAIDYN makes decision-ready intelligence actionable - safely, at scale and embedded into how teams work. ZAIDYN has specialized agents that monitor signals, recommend next best actions and execute governed workflows with human review, approval and override at every step. Building on the foundation of ZAIDYN Commercial, ZAIDYN Medical and ZAIDYN Content bring agentic AI into medical intelligence and the compliant content supply chain through a shared intelligence layer, so leaders can move faster, confidently and consistently. "ZS has spent decades helping life sciences teams solve their most complex commercial and medical challenges, and now we're packaging that expertise with agentic AI in our products," said Sunil Dixit, chief product officer at ZS. "We built these new product lines to address the pressure on life sciences organizations to do more with less. Agents grounded in domain and armed with rich ontologies can support and streamline medical, legal and regulatory (MLR) review workflows and deliver insights to medical affairs teams to help accelerate the speed of their work." ZAIDYN Medical ZAIDYN Medical is backed by ZS's extensive innovation and intellectual property portfolio, including issued U.S. patents and pending patent applications focused on AI-driven medical intelligence. Within the suite, ZAIDYN OLI(TM) includes capabilities related to technologies described in a recently granted U.S. patent, highlighting ZS's innovation in AI-driven opinion leader and influence network intelligence for life sciences. ZAIDYN Medical helps medical affairs teams identify, prioritize and engage key opinion leaders while generating end-to-end insights 50-70% faster. The platform also includes capabilities that help teams identify care gaps, measure patient outcomes, generate scientific and stakeholder insights, and support compliant medical engagement. "Medical affairs teams are under increasing pressure to focus their time and attention where it matters most," said Murali Gopal, MD, senior vice president and head of medical affairs at Ardelyx, Inc. "Approaches that help teams prioritize stakeholders and prepare for scientific engagement more effectively can support more focused conversations and greater continuity across interactions." ZAIDYN Content ZAIDYN Content is a purpose-built, flexible agentic AI suite designed to accelerate the life sciences content supply chain from creation through MLR approval and reuse. Its Content MLR Accelerator module embeds compliance, brand and medical intelligence directly into review workflows, helping teams improve submission readiness, streamline reviews and scale compliant content reuse and localization without increasing risk. ZAIDYN Content also supports content generation and personalization, enabling faster, compliant content reuse across brands, markets and languages. Deployed at enterprise scale, ZAIDYN Content has expedited more than 100,000 assets across brands, markets and languages, reducing cycle time for personalized and derivative content by over 67%. "The true value of innovation in life sciences is realized when it reaches the people who need it," said Jaideep Bajaj, chairman at ZS. "ZAIDYN Content helps organizations deliver important information to patients, providers and stakeholders with greater speed, supporting meaningful impact for all." Additional information about ZAIDYN is available at ZAIDYN.ai.
ZS, a global management consulting and technology firm, announced today the acquisition of Torrent Consulting, a Salesforce consulting partner who specialize...
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Consulting
Healthcare
Company Size
10,001+
Company Stage
N/A
Total Funding
N/A
Headquarters
Evanston, Illinois
Founded
1983
Find jobs on Simplify and start your career today